• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - IRVINE INFUSOR; PUMP, INFUSION, ELASTOMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - IRVINE INFUSOR; PUMP, INFUSION, ELASTOMERIC Back to Search Results
Catalog Number 2C1009KP
Device Problem Filling Problem (1233)
Patient Problem Seizures (2063)
Event Type  Injury  
Manufacturer Narrative
Date of event: the chemo treatment began on (b)(6) 2019 and the seizures occurred on (b)(6) 2019.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
A patient experienced an over infusion with an infusor pump which resulted in multiple seizures.It was reported the patient was undergoing a 46-hour chemo treatment (started on unreported time in the afternoon) with 480mg (dose banded) 5fu within 230ml civa.The following morning it was noted the infusor was ¿nearly empty¿.There was no liquid or precipitate noted around the infusor.It was reported ¿shortly after¿, the patient experienced seizure like activity and presented to the emergency department (ed), where the infusor was removed.While in the ed the patient experienced three seizures.The patient was administered unspecified ¿anti-seizure meds¿ (no further details).It was reported the pump was attached via a port and kept at chest level within a canvas container.The cause of the over infusion was not reported.At the time of this report, the patient was hospitalized, ¿stable and undergoing observation¿.No additional information is available.
 
Manufacturer Narrative
Additional information: the actual device was not available; however, a companion sample was received for evaluation.Visual inspection of the companion sample with the naked eye did not identify any abnormalities that could have contributed to the reported condition.Functional flow rate testing was performed on the companion sample and was found within the product specification range.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The cause of the condition could not be determined.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSOR
Type of Device
PUMP, INFUSION, ELASTOMERIC
Manufacturer (Section D)
BAXTER HEALTHCARE - IRVINE
irvine CA
Manufacturer (Section G)
BAXTER HEALTHCARE - IRVINE
17511 armstrong avenue
building 3
irvine CA 92614
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key8802995
MDR Text Key151450602
Report Number1416980-2019-03848
Device Sequence Number1
Product Code MEB
UDI-Device Identifier00085412081373
UDI-Public(01)00085412081373
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K071222
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date 08/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/02/2022
Device Catalogue Number2C1009KP
Device Lot Number19B008
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/26/2019
Initial Date FDA Received07/18/2019
Supplement Dates Manufacturer Received07/29/2019
Supplement Dates FDA Received08/23/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
5% DEXTROSE 1000ML; FLUOROURACIL (NONBAXTER)
Patient Outcome(s) Hospitalization; Required Intervention;
-
-